Corcept在内部收购价值超过300万美元后上涨

2026-03-20 23:00

Corcept Therapeutics (CORT) traded higher on Friday after the company’s board member Leonard Baker Jr. disclosed that he purchased shares of the Korlym maker in a transaction worth more than $3M earlier this week.
According to a regulatory filing on Thursday, Baker, Jr., who has been serving on the company's board as a director since 1999, has purchased 100,000 shares of Corcept (CORT) for an average price of about $33.14 apiece.
The share purchases worth more than $3.3M have increased Baker Jr.'s direct ownership in the company by ~2% to ~1.1M shares.
The purchases took place in two separate transactions on Tuesday, less than a month after an appeals court issued an unfavorable ruling against Corcept (CORT) in its patent dispute with Teva Pharmaceuticals (TEVA) related to Korlym.

More on Corcept Therapeutics